Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores

Satvinder S Dhaliwal1, Timothy A Welborn

  • 1School of Public Health, Curtin Health Innovation Research Institute, Australian Technology Network Centre for Metabolic Fitness, Curtin University of Technology, Bentley, Western Australia, Australia. s.dhaliwal@curtin.edu.au

Insights

Central obesity measurements, specifically waist-to-hip ratio and waist circumference, independently predict cardiovascular deaths. These central obesity metrics enhance risk prediction beyond the Framingham risk scores, especially in lower-risk individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality globally.
  • The Framingham risk score is a widely used tool for predicting CVD risk.
  • Central obesity is increasingly recognized as a significant health concern.

Purpose of the Study:

  • To assess the predictive value of central obesity measurements for cardiovascular risk.
  • To determine if waist circumference (WC) and waist-to-hip ratio (WHR) improve CVD risk prediction beyond the Framingham risk score.
  • To investigate the independent contribution of central obesity to cardiovascular mortality.

Main Methods:

  • A cohort study of 4,175 Australian men, free of cardiovascular disease and diabetes at baseline (1989).
  • Follow-up for mortality until 2004, recording baseline lipids, blood pressure, smoking, body mass index, WC, and WHR.
  • Cox proportional hazards regression analysis was used to evaluate predictors of coronary heart disease (CHD) and CVD deaths.

Main Results:

  • The Framingham equations effectively predicted CHD and CVD deaths.
  • Waist circumference (WC) and waist-to-hip ratio (WHR) independently predicted cardiovascular deaths, unlike body mass index.
  • WHR and WC added significant predictive value for cardiovascular outcomes, particularly in individuals with lower Framingham risk scores.

Conclusions:

  • Central obesity, measured by WC and WHR, is a significant and independent predictor of cardiovascular mortality.
  • These central obesity metrics contribute to residual cardiovascular risk not captured by the Framingham equations.
  • Incorporating central obesity measures may refine cardiovascular risk assessment, especially for individuals at lower traditional risk levels.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...